Overweight
📧 Sign up to get email alerts when something new happens for Overweight.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-28EMA Authorised: Mounjaro (tirzepatide) — Eli Lilly Nederland B.V.
The EMA authorizes Mounjaro (tirzepatide) for therapeutic use in type 2 diabetes, obesity, and overweight conditions.
-
EMA approval · 2026-08-26EMA Authorised: Wegovy (semaglutide) — Novo Nordisk A/S
EMA authorises Wegovy (semaglutide) by Novo Nordisk A/S for obesity and overweight.
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1) [Phase 2, Phase 3]
Phase 2/3 trial evaluating pharmacological and behavioral treatment after bariatric surgery for loss-of-control eating and obesity/overweigh…
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Update: Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1) [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating pharmacological and behavioral treatment after bariatric surgery for loss-of-control eating …
-
EMA approval · 2026-08-25EMA Authorised: Ablymico (liraglutide) — STADA Arzneimittel AG
Ablymico (liraglutide) has been authorised by EMA for obesity and overweight indications.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-08-18EMA Authorised: Mounjaro (tirzepatide) — Eli Lilly Nederland B.V.
EMA authorised Mounjaro (tirzepatide) for therapeutic use in type 2 diabetes mellitus, obesity, and overweight conditions.
-
CLINICAL_TRIALS trial_result · 2026-07-27Clinical Trial Update: A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity [Phase 3]
Phase 3 trial update for HRS-7535 tablets in overweight or obese subjects has completed.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities [Phase 1]
Phase 1 study results for LY3502970 in Chinese participants with overweight or obesity and weight-related comorbidities have been completed.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight [Phase 1]
Phase 1 trial comparing tablet and capsule forms of Orforglipron (LY3502970) in healthy overweight/obese participants; results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-10Clinical Trial Results: A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants [Phase 1]
Phase 1 multiple-dose study of LY3502970 in healthy overweight/obese participants completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity [NA]
Completed clinical trial evaluating produce prescription programs for adults with overweight or obesity experiencing nutrition insecurity; r…
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight [Phase 2]
Phase 2 trial results for LY3841136 versus placebo in adults with obesity or overweight have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight [Phase 3]
Phase 3 trial update for retatrutide (LY3437943) in participants without type 2 diabetes who have obesity or overweight; study status is act…
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: A Study of HS-20094 in Chinese Adults With Overweight or Obesity [Phase 3]
Phase 3 trial update for HS-20094 in Chinese adults with overweight or obesity has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN) [Phase 3]
Phase 3 trial update for orforglipron (ATTAIN-MAINTAIN) evaluating maintenance of body weight reduction in adults with obesity or overweight…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of HS-20094 in Chinese Adults With Overweight or Obesity [Phase 3]
Phase 3 clinical trial update for HS-20094 in Chinese adults with overweight or obesity has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight [Phase 3]
Phase 3 study of retatrutide (LY3437943) in participants with obesity or overweight has completed enrollment and is reporting results.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight [Phase 3]
A Phase 3 trial investigating the weight loss effect of NNC0487-0111 in adults with overweight/obesity and type 2 diabetes (recruiting).
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of different doses of NNC0662-0419 in overweight and obesity.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes [Phase 3]
An update on a Phase 3 master protocol evaluating Orforglipron (LY3502970) for obesity or overweight in participants with and without Type 2…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Hormonal Control of Energy and Macronutrient Intake in Obesity (MEMORY) [NA]
This clinical trial update indicates that the MEMORY study, investigating hormonal control of energy and macronutrient intake in obesity, is…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity [Phase 3]
A Phase 3 study of Orforglipron (LY3502970) in adults with obesity or overweight and at least one weight-related comorbidity is active but n…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Effect of a Protein Supplementation on Body Weight and Metabolic Variables in Overweight and Obese Patients [NA]
A completed clinical trial evaluating the effect of protein supplementation on body weight and metabolic variables in overweight and obese a…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity [Phase 1]
Pfizer is conducting a Phase 1 study to evaluate how PF-08653944 affects gastric emptying in healthy adults with overweight or obesity; the …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Weight Status, Resilience, and Quality of Life in Indian Children
A completed clinical trial update assessing weight status, resilience, and quality of life in Indian children.